Literature DB >> 11244620

[Incidence and surgical wound infection risk factors in breast cancer surgery].

D Lefebvre1, N Penel, M F Deberles, C Fournier.   

Abstract

BACKGROUND: In order to evaluate occurrence and risk factors for wound infection (WI) in breast cancer surgery, we carried out a prospective study.
METHODS: From September 1996 through April 1997, an infection control physician prospectively evaluated 542 wounds of all patients having breast cancer surgery at the Oscar Lambret Cancer Center. WI was defined as a wound with pus. Antibiotic prophylaxis was given in case of immediate breast reconstruction. Statistical evaluation was performed using the c < or = test for categorial data and non-parametric Mann-Whitney test for continuous data. In univariate analysis, differences were considered significant at p < 0.01.
RESULTS: The overall WI rate was 3.51% (19/352). In univariate analysis, risk factors for WI were: total preoperative hospital stay (p = 0.01), previous chemotherapy (p = 0.01), previous oncologic surgery (p = 0.03) and immediate breast reconstruction (p = 0.002). In mutivariate analysis, we observed two independent predictive factors for WI: previous chemotherapy (p = 0.05) and immediate breast reconstruction (p = 0.02).
CONCLUSIONS: Previous anticancer chemotherapy was a major risk factor. In these cases, a phase III trial could confirm efficacy of standard antibiotic prophylaxis. Breast reconstruction was the second major risk factor. Standard antibiotic prophylaxis (used in our study) was insufficient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11244620

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Surgical site infections in breast surgery: case-control study.

Authors:  Diana Vilar-Compte; Benedicte Jacquemin; Carlos Robles-Vidal; Patricia Volkow
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

2.  Risk factors for surgical site infection after major breast operation.

Authors:  Margaret A Olsen; Mellani Lefta; Jill R Dietz; Keith E Brandt; Rebecca Aft; Ryan Matthews; Jennie Mayfield; Victoria J Fraser
Journal:  J Am Coll Surg       Date:  2008-06-26       Impact factor: 6.113

3.  Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.

Authors:  Michael Gallagher; Daniel J Jones; Sophie V Bell-Syer
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26

Review 4.  Epidemiology of infections in cancer patients.

Authors:  Teresa R Zembower
Journal:  Cancer Treat Res       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.